VKTX Viking Therapeutics, Inc. - Common Stock
VKTX Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
VKTX Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
VKTX Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
- Compra fuerte 9 34,6%
- Compra 14 53,8%
- Mantener 3 11,5%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
19 analistas · 2026-08-19Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 30 de junio de 2026 | $-1.10 | $-1.27 | 0.17% |
| 31 de marzo de 2026 | $-1.37 | $-1.03 | -0.34% |
| 31 de diciembre de 2025 | $-1.38 | $-0.91 | -0.47% |
| 30 de septiembre de 2025 | $-0.81 | $-0.69 | -0.12% |
| 30 de junio de 2025 | $-0.58 | $-0.46 | -0.12% |
| 31 de marzo de 2025 | $-0.41 | $-0.33 | -0.08% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| VKTX | $4.04B | -11.0 | — | — | -47.3% | — |
| TNGX | $1.20B | -10.2 | 48.3% | -162.8% | -42.2% | — |
| LEGN | — | — | — | — | — | — |
| DNLI | $2.58B | -5.6 | 204.7% | — | -50.2% | — |
| RCUS | $2.99B | -7.2 | -4.3% | -142.9% | -59.8% | — |
| IDYA | $3.04B | -27.0 | 3024.4% | -52.0% | -11.5% | — |
| VCYT | $3.34B | 51.3 | 16.0% | 12.8% | 5.2% | 70.1% |
| IOVA | $1.12B | -2.5 | 60.6% | -148.4% | -56.0% | — |
| ARQT | $3.58B | -223.4 | 91.3% | -4.3% | -9.8% | — |
| GRAL | $3.45B | -7.7 | 17.2% | -277.5% | -16.7% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 14
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $345M | $102M | $64M | $54M | $45M | $32M | $24M | $19M | $14M | $9M | $7M | $22M | |
| SG&A Expense | $48M | $49M | $37M | $16M | $11M | $11M | $9M | $7M | $5M | $5M | $5M | $1M | |
| Operating Expenses | $393M | $151M | $101M | $70M | $56M | $43M | $33M | $26M | $19M | $14M | $12M | $23M | |
| Operating Income | $-393M | $-151M | $-101M | $-70M | $-56M | $-43M | $-33M | $-26M | $-19M | $-14M | $-12M | $-23M | |
| Other Non-op | $34M | $41M | $15M | $1M | $692.0K | $3M | $7M | $4M | $-2M | $-884.5K | $-11M | $2M | |
| Pretax Income | $-360M | $-110M | $-86M | · | · | · | · | · | · | · | · | · | |
| Income Tax | $1.0K | $1.0K | $1.0K | $1.0K | $2.0K | $0 | $0 | $0 | $0 | $0 | · | · | |
| Net Income | $-360M | $-110M | $-86M | $-69M | $-55M | $-39M | $-26M | $-22M | $-21M | $-15M | $-23M | $-22M | |
| EPS (Basic) | $-3.19 | $-1.01 | $-0.91 | $-0.90 | $-0.71 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-3.19 | $-1.01 | $-0.91 | $-0.90 | $-0.71 | · | · | · | · | · | · | · | |
| Shares (Basic) | 112,667,000 | 109,037,000 | 94,347,000 | 76,834,000 | 77,198,000 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 112,667,000 | 109,037,000 | 94,347,000 | 76,834,000 | 77,198,000 | · | · | · | · | · | · | · | |
| EBITDA | $-393M | $-151M | $-101M | $-70M | $-56M | $-43M | $-33M | $-26M | $-19M | $-14M | $-12M | · |
Balance general 16
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $166M | $27M | $56M | $37M | $26M | $29M | $8M | $25M | $9M | $3M | $768.5K | $755.9K | |
| Short-term Investments | · | · | · | · | · | $219M | $267M | $277M | $12M | $10M | $13M | · | |
| Prepaid Expense | $2M | $1M | $3M | $3M | $619.0K | $442.0K | $405.0K | $278.0K | $389.0K | $282.7K | $1M | $17.8K | |
| Current Assets | $716M | $907M | $367M | $167M | $211M | $256M | $284M | $302M | $22M | $14M | $15M | $773.7K | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | · | $775 | |
| Total Assets | $716M | $908M | $368M | $169M | $211M | $257M | $284M | $302M | $22M | $15M | $15M | $3M | |
| Accounts Payable | $53M | $10M | $8M | $9M | $1M | $4M | $2M | $959.0K | $2M | $1M | $592.4K | $2M | |
| Current Liabilities | $77M | $27M | $19M | $22M | $9M | $12M | $7M | $5M | $9M | $6M | $2M | $23M | |
| Capital Leases | $0 | $630.0K | $936.0K | $1M | · | $29.0K | $360.0K | · | · | · | · | · | |
| Total Liabilities | $77M | $28M | $20M | $23M | $9M | $12M | $7M | $5M | $9M | $6M | $7M | $25M | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $358 | $208 | $97 | $60 | |
| Retained Earnings | $-848M | $-488M | $-378M | $-292M | $-223M | $-168M | $-129M | $-103M | $-81M | $-60M | $-46M | $-22M | |
| Treasury Stock | $0 | $0 | $7M | $7M | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $639M | $880M | $348M | $145M | $202M | $244M | $277M | $298M | $13M | $8M | $9M | $-22M | |
| Liabilities + Equity | $716M | $908M | $368M | $169M | $211M | $257M | $284M | $302M | $22M | $15M | $15M | $3M | |
| Shares Outstanding | 114,793,067 | 111,573,519 | 100,113,770 | 78,257,258 | 78,248,401 | 73,215,940 | 72,413,602 | 71,742,043 | 35,817,104 | 20,823,873 | 9,683,741 | 6,000,000 |
Flujo de Efectivo 8
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $41M | $30M | $17M | $9M | $6M | $6M | $4M | $3M | $1M | $2M | $3M | $6.3K | |
| Operating Cash Flow | $-279M | $-88M | $-73M | $-48M | $-48M | $-22M | $-25M | $-19M | $-15M | $-11M | $-9M | $-2M | |
| Investing Cash Flow | $341M | $-553M | $-179M | $55M | $38M | $42M | $7M | $-266M | $-2M | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | $297M | $22M | $12M | $25M | · | |
| Stock Repurchased | · | · | · | $7M | · | · | · | · | · | $229 | $38 | $2 | |
| Net Stock Activity | · | · | · | $-7M | · | · | · | $297M | $22M | $12M | $25M | · | |
| Financing Cash Flow | $76M | $612M | $271M | $4M | $7M | $950.0K | $887.0K | $300M | $22M | · | · | · | |
| Net Change in Cash | · | · | · | $11M | $-3M | $21M | $-16M | $16M | $6M | $2M | $12.7K | $576.2K |
Rentabilidad 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -44.3% | -17.2% | -32.0% | -36.3% | -23.5% | -14.6% | -8.8% | -13.6% | -112.3% | -98.3% | -253.3% | · | |
| ROE | -47.3% | -17.9% | -34.8% | -39.7% | -24.6% | -15.2% | -9.0% | -14.2% | -191.3% | -175.7% | 349.2% | · | |
| ROIC | -61.6% | · | · | · | · | · | · | · | · | · | · | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.3 | 33.1 | 19.2 | 7.6 | 24.0 | 21.1 | 41.8 | 66.4 | 2.5 | 2.2 | 7.7 | · | |
| Quick Ratio | 2.2 | 1.0 | 2.9 | 1.7 | 3.0 | 20.5 | 40.7 | 66.3 | 2.4 | 2.0 | 7.1 | · |
Eficiencia 1
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · |
Valoración (TTM) 8
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Net Income TTM | $-360M | $-110M | $-86M | $-69M | $-55M | $-39M | $-26M | $-22M | $-21M | $-15M | $-23M | · | |
| Market Cap | $4.04B | $4.49B | $1.86B | $736M | $360M | $412M | $581M | $549M | $145M | $25M | $33M | · | |
| P/E | -11.0 | -39.8 | -20.5 | -10.4 | -6.5 | · | · | · | · | · | · | · | |
| P/B | 6.3 | 5.1 | 5.3 | 5.1 | 1.8 | 1.7 | 2.1 | 1.8 | 10.8 | 3.1 | 3.8 | · | |
| P / Tangible Book | 6.3 | 5.1 | 5.3 | 5.1 | 1.8 | 1.7 | · | · | · | · | · | · | |
| P / Cash Flow | -14.5 | -51.1 | -25.4 | -15.2 | -7.6 | -18.9 | -23.5 | -29.3 | -9.9 | -2.2 | -3.8 | · | |
| Earnings Yield | -9.1% | -2.5% | -4.9% | -9.6% | -15.4% | · | · | · | · | · | · | · |
Estado de resultados 12
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $116M | $150M | $153M | $90M | $60M | $41M | $31M | $23M | $24M | $24M | $18M | $14M | $11M | $12M | $14M | $13M | |
| SG&A Expense | $17M | $14M | $11M | $9M | $14M | $14M | $15M | $14M | $10M | $10M | $9M | $10M | $10M | $4M | $4M | $4M | |
| Operating Expenses | $133M | $164M | $165M | $99M | $75M | $55M | $46M | $37M | $34M | $34M | $27M | $24M | $21M | $16M | $18M | $16M | |
| Operating Income | $-133M | $-164M | $-165M | $-99M | $-75M | $-55M | $-46M | $-37M | $-34M | $-34M | $-27M | $-24M | $-21M | $-16M | $-18M | $-16M | |
| Other Non-op | $5M | $6M | $7M | $8M | $9M | $10M | $11M | $12M | $12M | $7M | $5M | $5M | $1M | $423.0K | $199.0K | $142.0K | |
| Net Income | $-128M | $-158M | $-158M | $-91M | $-66M | $-46M | $-35M | $-25M | $-22M | $-27M | $-23M | $-19M | $-20M | $-16M | $-17M | $-16M | |
| EPS (Basic) | $-1.10 | $-1.37 | $-1.39 | $-0.81 | $-0.58 | $-0.41 | $-0.33 | $-0.22 | $-0.20 | $-0.26 | $-0.23 | $-0.19 | $-0.25 | $-0.21 | $-0.23 | $-0.21 | |
| EPS (Diluted) | $-1.10 | $-1.37 | $-1.39 | $-0.81 | $-0.58 | $-0.41 | $-0.33 | $-0.22 | $-0.20 | $-0.26 | $-0.23 | $-0.19 | $-0.25 | $-0.21 | $-0.23 | $-0.21 | |
| Shares (Basic) | 116,263,000 | 115,568,000 | -223,856,000 | 112,320,000 | 112,134,000 | 112,069,000 | -215,721,000 | 110,911,000 | 110,390,000 | 103,457,000 | 99,846,000 | 99,010,000 | 78,352,000 | 76,505,000 | 76,842,000 | 77,413,000 | |
| Shares (Diluted) | 116,263,000 | 115,568,000 | -223,856,000 | 112,320,000 | 112,134,000 | 112,069,000 | -215,721,000 | 110,911,000 | 110,390,000 | 103,457,000 | 99,846,000 | 99,010,000 | 78,352,000 | 76,505,000 | 76,842,000 | 77,413,000 | |
| EBITDA | $-133M | $-164M | · | $-99M | $-75M | $-55M | · | $-37M | $-34M | $-34M | $-27M | $-24M | $-21M | $-16M | $-18M | $-16M |
Balance general 14
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $126M | $118M | $166M | $100M | $34M | $38M | $27M | $50M | $44M | $196M | $37M | $70M | $18M | $29M | $16M | $12M | |
| Prepaid Expense | $941.0K | $1M | $2M | $2M | $3M | $865.0K | $1M | $2M | $138.0K | $643.0K | $670.0K | $960.0K | $4M | $956.0K | $1M | $388.0K | |
| Current Assets | $518M | $608M | $716M | $739M | $827M | $866M | $907M | $937M | $946M | $966M | $381M | $399M | $149M | $165M | $180M | $193M | |
| Total Assets | $522M | $608M | $716M | $739M | $828M | $867M | $908M | $938M | $947M | $968M | $383M | $401M | $151M | $167M | $182M | $195M | |
| Accounts Payable | $69M | $67M | $53M | $4M | $5M | $8M | $10M | $254.0K | $11M | $5M | $6M | $6M | $4M | $3M | $6M | $3M | |
| Current Liabilities | $110M | $106M | $77M | $26M | $32M | $20M | $27M | $26M | $25M | $33M | $13M | $13M | $16M | $14M | $15M | $11M | |
| Capital Leases | $4M | $0 | $0 | $318.0K | $410.0K | $502.0K | $630.0K | $755.0K | $766.0K | $852.0K | $1M | $1M | $1M | $1M | $1M | $1M | |
| Total Liabilities | $114M | $106M | $77M | $26M | $32M | $20M | $28M | $26M | $26M | $34M | $14M | $15M | $17M | $15M | $16M | $13M | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | |
| Retained Earnings | $-1.13B | $-1.01B | $-848M | $-690M | $-599M | $-534M | $-488M | $-452M | $-428M | $-405M | $-353M | $-331M | $-312M | $-272M | $-257M | $-239M | |
| Treasury Stock | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $7M | $7M | $7M | $7M | $7M | $5M | |
| Stockholders' Equity | $408M | $502M | $639M | $713M | $795M | $847M | $880M | $911M | $921M | $934M | $368M | $386M | $134M | $151M | $165M | $182M | |
| Liabilities + Equity | $522M | $608M | $716M | $739M | $828M | $867M | $908M | $938M | $947M | $968M | $383M | $401M | $151M | $167M | $182M | $195M | |
| Shares Outstanding | 116,652,937 | 115,893,943 | 114,793,067 | 112,446,961 | 112,329,709 | 112,288,759 | 111,573,519 | 111,434,821 | 110,796,200 | 110,228,869 | 100,028,828 | 100,028,828 | 79,319,081 | 76,688,478 | 76,688,478 | 77,373,712 |
Flujo de Efectivo 7
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $11M | $10M | $9M | $7M | $14M | $11M | $6M | $9M | $7M | $8M | $4M | $5M | $4M | $2M | $2M | $2M | |
| Operating Cash Flow | $-125M | $-114M | $-85M | $-94M | $-47M | $-52M | $-31M | $-22M | $-29M | $-6M | $-20M | $-11M | $-25M | $-13M | $-13M | $-11M | |
| Investing Cash Flow | $109M | $54M | $76M | $160M | $43M | $63M | $7M | $26M | $-126M | $-460M | $-13M | $-204M | $2M | $27M | $19M | $2M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $2M | $5M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-5M | |
| Financing Cash Flow | $24M | $12M | $75M | $480.0K | $507.0K | $349.0K | $1M | $3M | $3M | $606M | $-74.0K | $267M | $4M | $10.0K | $-2M | $-5M | |
| Net Change in Cash | · | · | · | · | · | · | · | · | · | · | · | $51M | $-18M | $13M | $4M | $-14M |
Rentabilidad 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -19.0% | -21.5% | · | -10.8% | -7.4% | -5.0% | · | -3.8% | -3.3% | -4.9% | -8.2% | -6.6% | -11.3% | -8.1% | -8.3% | -7.2% | |
| ROE | -21.3% | -23.5% | · | -11.2% | -7.6% | -5.1% | · | -3.9% | -3.4% | -5.1% | -8.7% | -7.0% | -12.3% | -8.7% | -8.9% | -7.7% |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.7 | 5.7 | · | 28.3 | 25.9 | 44.2 | · | 36.5 | 37.7 | 29.5 | 28.4 | 29.6 | 9.6 | 11.7 | 12.1 | 17.2 | |
| Quick Ratio | 1.1 | 1.1 | · | 3.9 | 1.1 | 1.9 | · | 2.0 | 1.8 | 6.0 | 2.8 | 5.2 | 1.2 | 2.1 | 1.1 | 1.1 |
Eficiencia 1
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Valoración (TTM) 8
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-443M | $-360M | · | $-227M | $-158M | $-120M | · | $-97M | $-91M | $-89M | $-77M | $-72M | $-69M | $-63M | $-62M | $-59M | |
| Market Cap | $4.55B | $3.77B | · | $2.96B | $2.98B | $2.71B | · | $7.05B | $5.87B | $9.04B | $1.11B | $1.62B | $1.32B | $209M | $222M | $232M | |
| P/E | -10.1 | -10.3 | · | -13.0 | -18.8 | -22.2 | · | -69.6 | -60.2 | -88.2 | -12.6 | -18.4 | -18.5 | -3.3 | -3.6 | · | |
| P/B | 11.1 | 7.5 | · | 4.1 | 3.7 | 3.2 | · | 7.7 | 6.4 | 9.7 | 3.0 | 4.2 | 9.9 | 1.4 | 1.3 | 1.3 | |
| P / Tangible Book | 11.1 | 7.5 | · | 4.1 | 3.7 | 3.2 | · | 7.7 | 6.4 | 9.7 | 3.0 | 4.2 | 9.9 | 1.4 | 1.3 | 1.3 | |
| P / Cash Flow | · | -33.1 | · | · | · | -51.8 | · | · | · | -1473.6 | · | · | -53.6 | · | · | -22.0 | |
| Earnings Yield | -9.9% | -9.7% | · | -7.7% | -5.3% | -4.5% | · | -1.4% | -1.7% | -1.1% | -8.0% | -5.4% | -5.4% | -30.1% | -28.0% | · |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ingresos | $0 | $0 | $0 | $0 | $0 |
| Beneficio neto | $-360M | $-110M | $-86M | $-69M | $-55M |
| EPS Diluido | $-3.19 | $-1.01 | $-0.91 | $-0.90 | $-0.71 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio corriente | 9.3 | 33.1 | 19.2 | 7.6 | 24.0 |
| Ratio Rápido | 2.2 | 1.0 | 2.9 | 1.7 | 3.0 |
Últimas noticias Noticias recientes que mencionan a esta empresa
- 2 Beaten-Down Stocks With Massive Upside Potential
- Is Viking Therapeutics Stock a No-Brainer Buy Below $35?
- Is Viking Therapeutics Stock Going to $100?
- Why 1 Wall Street Analyst Thinks Viking Therapeutics Stock Could Soar 188%
- 1 Razón por la que esta acción de biotecnología podría triplicarse antes de fin de año
- ¿Tienes $1,500? ¿Es Mejor Comprar Bitcoin o Viking Therapeutics?
- Qué saber sobre este desarrollador de medicamentos para la obesidad que acaba de recibir una nueva inversión de $7 millones
Señales de trading Señales recientes de compra/venta con precio de entrada y ratio riesgo/recompensa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 501 declarantes · $2.6B total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 91 (+22 vs trimestre anterior) | 44 (-25 vs trimestre anterior) | 140 (-19 vs trimestre anterior) | 126 (+6 vs trimestre anterior) | +14.6M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| STATE STREET CORP | $218 705 430 | 5 606 394 | 8,31% | Acciones |
| FMR LLC | $197 202 455 | 5 055 177 | 7,49% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $197 143 394 | 5 053 663 | 7,49% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $174 931 100 | 4 484 263 | 6,65% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $153 598 520 | 3 937 414 | 5,83% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $113 382 565 | 2 906 500 | 4,31% | Opción de compra |
| TWO SIGMA ADVISERS, LP | $74 906 241 | 2 129 228 | 2,85% | Acciones |
| AMERICAN CENTURY COMPANIES INC | $70 844 186 | 1 816 050 | 2,69% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $69 510 737 | 1 781 277 | 2,64% | Acciones |
| D. E. Shaw & Co., Inc. | $62 649 826 | 1 605 994 | 2,38% | Acciones |
| DIADEMA PARTNERS LP | $47 623 408 | 1 220 800 | 1,81% | Opción de compra |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $46 039 602 | 1 180 200 | 1,75% | Opción de venta |
| CITADEL ADVISORS LLC | $43 773 121 | 1 122 100 | 1,66% | Opción de compra |
| BNP PARIBAS FINANCIAL MARKETS | $38 296 117 | 981 700 | 1,45% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $31 846 477 | 816 367 | 1,21% | Acciones |
| GOLDMAN SACHS GROUP INC | $30 821 099 | 790 082 | 1,17% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $28 557 153 | 732 047 | 1,08% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $28 504 217 | 730 690 | 1,08% | Acciones |
| Pictet Asset Management Holding SA | $26 640 280 | 682 909 | 1,01% | Acciones |
| Vestal Point Capital, LP | $26 526 800 | 680 000 | 1,01% | Acciones |
| AMERIPRISE FINANCIAL INC | $24 858 186 | 637 226 | 0,94% | Acciones |
| CITADEL ADVISORS LLC | $23 530 832 | 603 200 | 0,89% | Opción de venta |
| Eversept Partners, LP | $23 519 987 | 602 922 | 0,89% | Acciones |
| BlackBarn Capital Partners LP | $23 406 000 | 600 000 | 0,89% | Acciones |
| JANE STREET GROUP, LLC | $22 996 200 | 589 495 | 0,87% | Acciones |
| ADAR1 Capital Management, LLC | $22 393 222 | 574 038 | 0,85% | Acciones |
| JANE STREET GROUP, LLC | $20 870 350 | 535 000 | 0,79% | Opción de compra |
| DIMENSIONAL FUND ADVISORS LP | $20 787 961 | 532 888 | 0,79% | Acciones |
| Connor, Clark & Lunn Investment Management Ltd. | $20 698 979 | 530 607 | 0,79% | Acciones |
| Caption Management, LLC | $20 511 458 | 525 800 | 0,78% | Opción de compra |
| TANG CAPITAL MANAGEMENT LLC | $19 505 000 | 500 000 | 0,74% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $19 433 690 | 498 172 | 0,74% | Acciones |
| Point72 Asset Management, L.P. | $18 463 745 | 473 308 | 0,70% | Acciones |
| Clearbridge Investments, LLC | $17 350 907 | 444 781 | 0,66% | Acciones |
| DIADEMA PARTNERS LP | $17 234 930 | 441 808 | 0,65% | Acciones |
| BLAIR WILLIAM & CO/IL | $16 258 035 | 416 766 | 0,62% | Acciones |
| RAYMOND JAMES FINANCIAL INC | $15 513 614 | 397 683 | 0,59% | Acciones |
| BlackRock, Inc. | $15 432 395 | 395 601 | 0,59% | Acciones |
| ExodusPoint Capital Management, LP | $15 346 650 | 393 000 | 0,58% | Opción de compra |
| Walleye Trading LLC | $14 964 236 | 383 600 | 0,57% | Opción de compra |
| First Washington CORP | $14 874 513 | 381 300 | 0,57% | Acciones |
| ExodusPoint Capital Management, LP | $14 087 525 | 361 126 | 0,54% | Acciones |
| Steward Partners Investment Advisory, LLC | $13 699 454 | 351 178 | 0,52% | Acciones |
| DIADEMA PARTNERS LP | $13 673 005 | 350 500 | 0,52% | Opción de venta |
| JANE STREET GROUP, LLC | $12 955 221 | 332 100 | 0,49% | Opción de venta |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $12 877 000 | 330 100 | 0,49% | Acciones |
| Woodline Partners LP | $11 810 317 | 302 751 | 0,45% | Acciones |
| GROUP ONE TRADING LLC | $10 198 891 | 261 443 | 0,39% | Acciones |
| WASATCH ADVISORS LP | $10 190 161 | 313 158 | 0,39% | Acciones |
| PFM Health Sciences, LP | $9 960 423 | 255 330 | 0,38% | Acciones |
| BlackBarn Capital Partners LP | $9 752 500 | 250 000 | 0,37% | Opción de compra |
| Gotham Asset Management, LLC | $9 001 050 | 230 737 | 0,34% | Acciones |
| BANK OF AMERICA CORP /DE/ | $8 875 595 | 227 521 | 0,34% | Acciones |
| Swiss National Bank | $8 617 309 | 220 900 | 0,33% | Acciones |
| Nuveen Asset Management, LLC | $8 168 680 | 202 999 | 0,31% | Acciones |
| ACT CAPITAL MANAGEMENT, LLC | $8 164 793 | 209 300 | 0,31% | Acciones |
| AQR CAPITAL MANAGEMENT LLC | $7 833 596 | 200 810 | 0,30% | Acciones |
| TUDOR INVESTMENT CORP ET AL | $7 697 882 | 197 331 | 0,29% | Acciones |
| Cetera Investment Advisers | $7 199 003 | 184 543 | 0,27% | Acciones |
| WOLVERINE TRADING, LLC | $7 128 722 | 276 200 | 0,27% | Opción de compra |
| Artia Global Partners LP | $7 050 316 | 180 731 | 0,27% | Acciones |
| LPL Financial LLC | $6 377 862 | 163 493 | 0,24% | Acciones |
| KORNITZER CAPITAL MANAGEMENT INC /KS | $6 072 375 | 155 662 | 0,23% | Acciones |
| Granahan Investment Management, LLC | $5 775 196 | 148 044 | 0,22% | Acciones |
| OPPENHEIMER & CO INC | $5 705 564 | 146 259 | 0,22% | Acciones |
| RFG Advisory, LLC | $5 570 234 | 142 790 | 0,21% | Acciones |
| UBS Group AG | $5 212 672 | 133 624 | 0,20% | Acciones |
| Rhenman & Partners Asset Management AB | $4 993 280 | 128 000 | 0,19% | Acciones |
| Balyasny Asset Management L.P. | $4 521 493 | 115 906 | 0,17% | Acciones |
| RHUMBLINE ADVISERS | $4 455 330 | 114 211 | 0,17% | Acciones |
| FIRST TRUST ADVISORS LP | $4 437 402 | 113 751 | 0,17% | Acciones |
| Persistent Asset Partners Ltd | $4 397 831 | 112 736 | 0,17% | Acciones |
| Trexquant Investment LP | $4 388 586 | 112 499 | 0,17% | Acciones |
| VANGUARD ASSET MANAGEMENT, Ltd | $4 273 936 | 109 560 | 0,16% | Acciones |
| Institute for Wealth Management, LLC. | $4 238 164 | 108 643 | 0,16% | Acciones |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $4 049 668 | 124 452 | 0,15% | Acciones |
| Caption Management, LLC | $4 006 327 | 102 700 | 0,15% | Opción de venta |
| Rafferty Asset Management, LLC | $3 880 520 | 99 475 | 0,15% | Acciones |
| Quantum Private Wealth, LLC | $3 837 238 | 98 365 | 0,15% | Acciones |
| Man Group plc | $3 718 979 | 95 334 | 0,14% | Acciones |
| LBP AM SA | $3 663 273 | 93 906 | 0,14% | Acciones |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $3 642 910 | 93 384 | 0,14% | Acciones |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $3 574 642 | 91 634 | 0,14% | Acciones |
| AXQ CAPITAL, LP | $3 566 957 | 91 437 | 0,14% | Acciones |
| WINTON GROUP Ltd | $3 532 199 | 90 546 | 0,13% | Acciones |
| TUDOR INVESTMENT CORP ET AL | $3 510 900 | 90 000 | 0,13% | Opción de compra |
| Bridgewater Associates, LP | $3 427 380 | 87 859 | 0,13% | Acciones |
| VANGUARD GROUP INC | $3 364 967 | 95 650 | 0,13% | Acciones |
| Cornerstone Capital, Inc. | $3 334 185 | 85 470 | 0,13% | Acciones |
| EXCHANGE TRADED CONCEPTS, LLC | $3 167 066 | 81 186 | 0,12% | Acciones |
| 683 Capital Management, LLC | $3 120 800 | 80 000 | 0,12% | Opción de compra |
| CAPITAL FUND MANAGEMENT S.A. | $2 934 176 | 75 216 | 0,11% | Acciones |
| Odyssean, LLC | $2 925 243 | 74 987 | 0,11% | Acciones |
| D. E. Shaw & Co., Inc. | $2 921 849 | 74 900 | 0,11% | Opción de compra |
| Y-Intercept (Hong Kong) Ltd | $2 825 884 | 72 440 | 0,11% | Acciones |
| WOLVERINE TRADING, LLC | $2 813 290 | 109 000 | 0,11% | Opción de venta |
| Lewis Asset Management, LLC | $2 605 478 | 66 790 | 0,10% | Acciones |
| Summit Financial, LLC | $2 605 301 | 66 785 | 0,10% | Acciones |
| CITADEL ADVISORS LLC | $2 599 743 | 66 643 | 0,10% | Acciones |
| MONIMUS CAPITAL MANAGEMENT, LP | $2 594 243 | 66 502 | 0,10% | Acciones |
Informantes de la empresa 16 insiders · 9 directivos · 7 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Brian Lian | President & CEO | 29 de julio de 2026 S | 2 572 441 | 0 | 6 | $-14 005 897 |
| Greg Zante | Chief Financial Officer | 29 de julio de 2026 S | 212 204 | 0 | 6 | $-2 823 737 |
| Marianna Mancini | Chief Operating Officer | 29 de julio de 2026 S | 422 760 | 0 | 6 | $-2 727 473 |
| Michael Dinerman | Chief Operating Officer | 4 de mayo de 2015 C | 694 116 | 0 | 0 | $0 |
| Hubert C Chen | Chief Medical Officer | 1 de junio de 2026 A | — | 0 | 0 | $0 |
| Neil William Aubuchon | Chief Commercial Officer | 10 de marzo de 2026 P | 4 475 | 1 | 0 | $149 912 |
| Michael Morneau | VP, Finance and Administration | 19 de enero de 2021 F | 116 062 | 0 | 0 | $0 |
| Hiroko Masamune | Chief Development Officer | 3 de enero de 2019 A | 141 063 | 0 | 0 | $0 |
| Rochelle Hanley | Chief Medical Officer | 4 de mayo de 2016 F | 160 836 | 0 | 0 | $0 |
| Sarah Kathryn Rouan | Consejero | 2 de enero de 2026 A | 4 390 | 0 | 0 | $0 |
| Lawson Macartney | Consejero | 2 de enero de 2026 A | 51 115 | 0 | 0 | $0 |
| Charles A Rowland Jr | Consejero | 2 de enero de 2026 A | 33 150 | 0 | 1 | $-2 134 200 |
| Matthew J Singleton | Consejero | 2 de enero de 2026 A | 12 650 | 0 | 0 | $0 |
| Matthew W Foehr | Consejero | 2 de enero de 2026 A | 135 186 | 0 | 1 | $-561 760 |
| Stephen W Webster | Consejero | 2 de enero de 2020 A | 8 000 | 0 | 0 | $0 |
| Dorothy Elizabeth Kelly-Gemmell | — | 1 de agosto de 2026 A | 6 333 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 58 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| SBIO · ALPS ETF Trust | 2,41% | 119 108 NS | 31 de mayo de 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,82% | 135 757 NS | 30 de abril de 2026 | N-PORT |
| MID · AMERICAN CENTURY ETF TRUST | 0,75% | 22 931 NS | 31 de mayo de 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,62% | 7 443 NS | 30 de abril de 2026 | N-PORT |
| HRTS · Tema ETF Trust | 0,54% | 8 538 NS | 31 de mayo de 2026 | N-PORT |
| EVNT · AltShares Trust | 0,53% | 2 000 NS | 31 de mayo de 2026 | N-PORT |
| FMED · Fidelity Covington Trust | 0,43% | 5 422 NS | 31 de mayo de 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 0,39% | 109 034 NS | 30 de abril de 2026 | N-PORT |
| ESSC · Strategy Shares | 0,31% | 2 593 NS | 30 de abril de 2026 | N-PORT |
| TMFX · RBB Fund, Inc. | 0,19% | 1 854 NS | 31 de mayo de 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,15% | 3 856 NS | 30 de abril de 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,12% | 1 464 336 SH | 8 de agosto de 2026 | Diario |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,10% | 24 522 SH | 8 de agosto de 2026 | Diario |
| SCHA · SCHWAB STRATEGIC TRUST | 0,08% | 555 687 NS | 31 de mayo de 2026 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,07% | 42 871 NS | 30 de abril de 2026 | N-PORT |
| ISCV · iShares Trust | 0,06% | 12 964 SH | 8 de agosto de 2026 | Diario |
| IYH · iShares Trust | 0,06% | 67 702 SH | 8 de agosto de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,06% | 330 703 SH | 8 de agosto de 2026 | Diario |
| ISCB · iShares Trust | 0,06% | 4 916 SH | 8 de agosto de 2026 | Diario |
| ESML · iShares Trust | 0,06% | 48 314 SH | 8 de agosto de 2026 | Diario |
| FHLC · FIDELITY COVINGTON TRUST | 0,05% | 49 795 NS | 30 de abril de 2026 | N-PORT |
| ISCG · iShares Trust | 0,05% | 15 800 SH | 8 de agosto de 2026 | Diario |
| SMMD · iShares Trust | 0,05% | 56 428 SH | 8 de agosto de 2026 | Diario |
| VXF · VANGUARD INDEX FUNDS | 0,05% | 1 332 828 SH | 8 de agosto de 2026 | Diario |
| VB · VANGUARD INDEX FUNDS | 0,05% | 2 530 231 SH | 8 de agosto de 2026 | Diario |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,04% | 30 721 SH | 8 de agosto de 2026 | Diario |
| IWS · iShares Trust | 0,03% | 158 556 SH | 8 de agosto de 2026 | Diario |
| WSML · iShares Trust | 0,03% | 6 482 SH | 8 de agosto de 2026 | Diario |
| SMLF · iShares Trust | 0,03% | 39 883 SH | 8 de agosto de 2026 | Diario |
| IWR · iShares Trust | 0,03% | 460 084 SH | 8 de agosto de 2026 | Diario |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,02% | 4 353 NS | 31 de mayo de 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,02% | 56 NS | 31 de mayo de 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,01% | 48 308 NS | 30 de abril de 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 35 206 NS | 31 de mayo de 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 3 501 108 SH | 8 de agosto de 2026 | Diario |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,01% | 19 254 SH | 8 de agosto de 2026 | Diario |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 63 630 SH | 8 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 9 458 SH | 8 de agosto de 2026 | Diario |
| ESGV · VANGUARD WORLD FUND | 0,01% | 25 563 SH | 8 de agosto de 2026 | Diario |
| GVUS · Goldman Sachs ETF Trust | 0,01% | 1 208 NS | 31 de mayo de 2026 | N-PORT |
| IWD · iShares Trust | 0,01% | 233 811 SH | 8 de agosto de 2026 | Diario |
| REVS · Columbia ETF Trust I | 0,01% | 791 NS | 30 de abril de 2026 | N-PORT |
| IWP · iShares Trust | 0,01% | 47 914 SH | 8 de agosto de 2026 | Diario |
| ITOT · iShares Trust | 0,01% | 158 925 SH | 8 de agosto de 2026 | Diario |
| TILT · FlexShares Trust | 0,01% | 3 542 NS | 30 de abril de 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,01% | 71 527 NS | 31 de mayo de 2026 | N-PORT |
| IWB · iShares Trust | 0,01% | 73 384 SH | 8 de agosto de 2026 | Diario |
| RECS · Columbia ETF Trust I | 0,00% | 8 429 NS | 30 de abril de 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 27 831 SH | 8 de agosto de 2026 | Diario |
| MSLC · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 4 089 NS | 31 de mayo de 2026 | N-PORT |